Bruker Corp (BRKR): Wolf-dieter Emmerich , director of Bruker Corp sold 21,000 shares on May 9, 2016. The Insider selling transaction was reported by the company on May 11, 2016 to the Securities and Exchange Commission. The shares were sold at $27.35 per share for a total value of $574,364.69 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 14, 2016, Mark Munch (Exec VP&Pres Bruker Nano Inc.) sold 75,000 shares at $27.70 per share price.On Jun 17, 2015, Frank H Laukien (CEO) purchased 1,000,000 shares at $19.50 per share price.Also, On Jun 17, 2015, Joerg C Laukien (director 10% owner) sold 1,000,000 shares at $19.50 per share price.On Jun 15, 2015, Stephen W. Fesik (director) sold 15,000 shares at $20.48 per share price.
Bruker Corporation: On Tuesday, May 10, 2016 heightened volatility was witnessed in Bruker Corporation which led to swings in the share price. The shares opened for trading at $27.25 and hit $27.64 on the upside , eventually ending the session at $27.61, with a gain of 1.40% or 0.38 points. The heightened volatility saw the trading volume jump to 11,73,004 shares. The 52-week high of the share price is $29.85 and the company has a market cap of $4,458 M . The 52-week low of the share price is at $15.778.
Company has been under the radar of several Street Analysts.Bruker Corporation is Reiterated by Mizuho to Neutral and the brokerage firm has raised the Price Target to $ 28 from a previous price target of $22 .The Rating was issued on May 5, 2016.Bruker Corporation is Reiterated by Barclays to Overweight and the brokerage firm has raised the Price Target to $ 32 from a previous price target of $30 .The Rating was issued on May 5, 2016.Bruker Corporation is Downgraded by Leerink Partners to Mkt Perform. Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Apr 5, 2016.Bruker Corporation is Downgraded by BofA/Merrill to Underperform. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Apr 5, 2016.Bruker Corporation is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 32 from a previous price target of $25 .The Rating was issued on Mar 14, 2016.
Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research pharmaceuticals applied markets nanotechnology cell biology clinical research microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group the Bruker CALID Group and the Bruker Nano Group. BEST designs manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America and it has sales offices located throughout the world.